trial

Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT)

NCTId NCT03427580
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 54 (actual)
Sponsored by Bar-Ilan University, Israel
Primary completion 2021-03-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
54 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2018-03-01
Primary completion
2021-03-01
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
MERIT

Sponsors

Bar-Ilan University, IsraelLead Sponsor

Sites

1 total
Ramat Gan, Israel

Facts & assertions

4 sourced
Enrollment
54
Phase
NA
Primary Completion Date
2021-03-01
Status
COMPLETED
relationships
The graph out of here
drug
MERIT
drug
lead_sponsor
Bar-Ilan University, Israel
company
indication
Schizophrenia
indication
Diagnosis of Schizophrenia Spectrum Disorders
indication